- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Breast firm HumaScan slashes work force
Citing "severe liquidity problems," breast cancer detection firm HumaScan of Cranford, NJ, has laid off most of its work force and is pursuing strategic alternatives that could result in the sale of the company. The firm said it is taking the approach
Citing "severe liquidity problems," breast cancer detection firm HumaScan of Cranford, NJ, has laid off most of its work force and is pursuing strategic alternatives that could result in the sale of the company. The firm said it is taking the approach due to slow sales of its BreastAlert TDS system, which is designed to detect breast pathology by measuring differences in skin temperature in breast tissue.
Sales of BreastAlert TDS began earlier this year, but the product has generated revenues of only $57,000 in the company's most recent quarter (end-June). That has led to a cash-flow shortage at the firm, a situation that has been complicated by the company's declining stock price and generally turbulent conditions on Wall Street.
HumaScan executives said on Nov. 4 that the company has reduced its personnel from 17 employees to four. The company is also seeking additional funding, with the option of selling the firm if necessary.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
